Back to Results
First PageMeta Content
Piperidines / Anilides / Ketones / General anesthetics / Duragesic / Fentanyl / Transdermal patch / Actiq / 3-Methylfentanyl / Chemistry / Organic chemistry / Pharmacology


Document Date: 2004-11-12 10:46:33

Open Document

File Size: 4,09 MB

Share Result on Facebook

Company

Johnson & Johnson / JanssenPharmaceuticalsv / MedLine / Duragesic In 1981 / Alza Corporation / Mylan Technologies / /

Continent

Europe / /

Country

United States / /

Event

FDA Phase / Product Issues / Reorganization / Person Communication and Meetings / /

Facility

National Library of Medicine’s MedLine / /

IndustryTerm

drug product / generic product / proposed generic product / Internet web / transdermal systems / generic transdermalfentanyl product / state law enforcementsources / involving fentanyl transdermal systems / /

MedicalCondition

chronic pain / intractable pain / managementof chronic pain / analgesic.Under-treatmentof chronic pain / hypertension / pain / prescription drug abuse / breakthrough pain / drug abuse / both cancer / prescription-drug abuse / /

Organization

Food and Drug Administration / Drug Abuse Unit / National Institute on Drug Abuse / FDA’s office of Generic Drugs / White House / office of National Drug Control Policy / American Medical Association / FDA / SubstanceAbuse and Mental Health Services Administration / Drug Enforcement Administration / /

Person

Victor Goetz / William E. Brochu / John Coleman / Gary Buehler / Gale Goetz / Eun Soo Lee / Su / Robert Gale / Generic Drugs / /

Position

advisors / physician / head / Director / Commissioner / physicians and other advisors / /

Product

Duragesic / Actiq / fentanyl / OxyContin / nicotine / Approved Drug / generic transdermalfentanyl product / January23 / Mylan / Europe / /

ProvinceOrState

Allegheny County / /

PublishedMedium

the Journal of the American Medical Association / /

Region

Western Pennsylvania / /

URL

www.fda.gov/cder/nuidancel5766dft.htm / /

SocialTag